HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Portfolio Tracker
Get an update on your stocks every day. See earnings revisions, new reports and Zacks Rank changes at a glance. Click here to learn more.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Top 10 Stocks
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


MYL: Mylan Inc - Stock News Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Company News |  Zacks Commentary
MYLAN INC (NASD)
MYL 17.55 0.12 (0.69%) Vol.  4,093,232 16.00 CST

Nov 20, 2009 Stock research report available on Mylan (NASDAQ:MYL) from SmarTrend Analytics
Nov 18, 2009 Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
Nov 13, 2009 Mylan Up 27.7% Since SmarTrend's Buy Recommendation
Nov 12, 2009 Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier
Nov 11, 2009 United States : Mylan subsidiary receives FDA approval for its Lansoprazole DR Capsules ANDA
Nov 11, 2009 Mylan Inc awarded FDA approval for generic Prevacid DR Capsules
Nov 10, 2009 Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories
Nov 05, 2009 Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services, Teva Pharmaceutical Industries Ltd., Mylan and Comcast Corp.
Nov 05, 2009 PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited
Nov 04, 2009 Mylan Laboratories (MYL) NewsBite - MYL Hits 52-Week High
Nov 04, 2009 Mylan Up 25.3% Since SmarTrend's Buy Recommendation
Oct 30, 2009 Zacks Analyst Blog Highlights: Bank of America, Citigroup, Motorola Inc., China Mobile Ltd. and Mylan, Inc.
Oct 29, 2009 Mylan Up 21.1% Since SmarTrend's Buy Recommendation
Oct 29, 2009 Mylan Laboratories Raises Guidance
Oct 29, 2009 Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32
 
ZACKS COMMENTARY FOR MYL
Nov 13, 2009 Zacks Blog: Another Win for Mylan
Nov 05, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services, Teva Pharmaceutical Industries Ltd., Mylan and Comcast Corp.
Nov 04, 2009 Zacks Blog: Teva Reports Strong Quarter
Nov 04, 2009 Zacks Equity Research: Report for MYL
Oct 30, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Bank of America, Citigroup, Motorola Inc., China Mobile Ltd. and Mylan, Inc.
Oct 29, 2009 Zacks Blog: Mylan Beats, Raises Outlook
Oct 15, 2009 Zacks Blog: Mylan Settles Dispute with Pfizer
Sep 29, 2009 Zacks Blog: Nuvigil Granted Priority Review
Sep 29, 2009 Zacks Blog: Salix Hopeful on New Indications
Sep 16, 2009 Zacks Blog: Teva’s Copaxone Challenged
Sep 15, 2009 Zacks Blog: Salix Scores on Rifaximin Data
Aug 31, 2009 Zacks Blog: Zacks Analyst Blog Highlights: Mylan, Sanofi-Aventis, Gilead Sciences, GlaxoSmithKline and Freddie Mac

 
About Zacks | Advertise | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2009 Zacks Investment Research